Sales of medication to treat ulcerative colitis in seven key markets are expected to double over the next decade, reaching $3.7 billion by 2021, according new research. The rapid growth will be largely driven by two premium-priced tumour necrosis factor-alpha (TNF-alpha) inhibitors – Abbott/Eisai’s Humira and Janssen/Merck/Mitsubishi Tanabe’s Simponi – and two novel therapies –
We would like to wish all our clients and candidates a very merry Christmas and a happy new year! Thank you for your business in 2012. We look forward to working with you in 2013! Only Medics will be closed from the afternoon of the 24th December 2012 until the 2nd January 2013. If you
A recent study has found that the use of antibiotics to treat persistent coughs (not caused by pneumonia) is ineffective. The European study involved 2,061 patients with acute lower-respiratory-tract infections where pneumonia was not suspected, and the patients were randomised to receive either amoxicillin or a placebo. The findings showed that neither the duration of
ACM Global Central Laboratory, the US-headquartered laboratory testing operation that raised its European profile in March 2009 by acquiring Pivotal Laboratories, have relocated their European laboratory to a bigger facility in York’s Hospital Fields Road. ACM Global confirmed that they have outgrown their prior facility in Aviator Court, York, which they have occupied since 1999.
GW Pharma has released mixed results for the year, with sales rising and profits decreasing, but the company continues to demonstrate potential in their R&D pipeline with inspiring data for a mid-stage, cannaboid-based diabetes drug. The organisation saw their sales for the year ending September 30, 2012, increase by £3.5 million to reach £33.1 million,
In his initial speech to primary care chiefs as Secretary of State for Health, Jeremy Hunt stressed his confidence in enlisting GPs at the centre of the new commissioning system, even though he acknowledged that GPs are being ‘overstretched’ already. Hunt informed delegates at the NHS Alliance conference that he believes that they “have won
Bayer have declared that they are not going to follow plans to purchase American vitamins company, Schiff Nutrition International, four days after their $1.20 billion offer was beaten by Reckitt Benckiser. Roughly three weeks ago, Bayer announced a bid of $34 per share to acquire Schiff, but Reckitt since revealed an offer of $42.00 per
New and expensive treatments are continuing to drive up NHS prescribing costs in England’s hospitals. This is according to a new IMS Health report, commissioned by the NHS, which found that hospital prescribing costs in England increased by 6.9% in 2011, far outstripping the 1.9% growth seen in primary care. The rate of increase is
New research presented yesterday, claims that the total yearly price tag of all cancers to the UK economy is currently £15.8 billion, of which lung cancer accounts for £2.4 billion – far greater than any other type of the disease. The results of the research highlight the on-going need to tackle smoking, which causes more
Novo Nordisk revealed more healthy sales figures yesterday for their third quarter results, aided by solid sales of their diabetes drug, Victoza, and its modern insulins. The company announced an 18% growth in sales to a total of 57.1 billion Danish kroner ($9.9 billion). Operating profit increased 34% to 21.9 billion kroner. Their net profit
